Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell of proximal tubule | 9 studies | 45% ± 13% | |
hepatocyte | 6 studies | 58% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 28483.92 | 226 / 226 | 84% | 201.15 | 340 / 406 |
kidney | 100% | 16037.85 | 89 / 89 | 79% | 136.97 | 712 / 901 |
bladder | 95% | 1114.14 | 20 / 21 | 25% | 29.91 | 127 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.43 | 1 / 1 |
stomach | 99% | 178.69 | 355 / 359 | 1% | 0.07 | 2 / 286 |
adrenal gland | 87% | 36.15 | 225 / 258 | 9% | 1.57 | 21 / 230 |
thymus | 92% | 55.90 | 598 / 653 | 0% | 0 | 0 / 605 |
adipose | 86% | 66.90 | 1036 / 1204 | 0% | 0 | 0 / 0 |
breast | 80% | 53.26 | 368 / 459 | 0% | 0 | 0 / 1118 |
prostate | 78% | 34.67 | 191 / 245 | 0% | 0 | 0 / 502 |
esophagus | 72% | 173.80 | 1035 / 1445 | 1% | 0.03 | 1 / 183 |
intestine | 67% | 50.70 | 652 / 966 | 1% | 0.24 | 4 / 527 |
blood vessel | 57% | 18.96 | 761 / 1335 | 0% | 0 | 0 / 0 |
uterus | 51% | 21.51 | 86 / 170 | 2% | 1.59 | 11 / 459 |
brain | 49% | 22.74 | 1285 / 2642 | 0% | 0 | 0 / 705 |
ovary | 48% | 14.36 | 87 / 180 | 0% | 0.08 | 1 / 430 |
lung | 33% | 7.97 | 188 / 578 | 1% | 0.64 | 11 / 1155 |
skin | 30% | 9.20 | 540 / 1809 | 0% | 0.06 | 2 / 472 |
heart | 24% | 6.87 | 209 / 861 | 0% | 0 | 0 / 0 |
pancreas | 12% | 2.54 | 38 / 328 | 5% | 3.62 | 9 / 178 |
peripheral blood | 16% | 22.94 | 153 / 929 | 0% | 0 | 0 / 0 |
muscle | 10% | 2.38 | 77 / 803 | 0% | 0 | 0 / 0 |
spleen | 4% | 9.90 | 9 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.38 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0046500 | Biological process | S-adenosylmethionine metabolic process |
GO_0071267 | Biological process | L-methionine salvage |
GO_0006479 | Biological process | protein methylation |
GO_0006579 | Biological process | amino-acid betaine catabolic process |
GO_0050666 | Biological process | regulation of homocysteine metabolic process |
GO_0071266 | Biological process | 'de novo' L-methionine biosynthetic process |
GO_0006577 | Biological process | amino-acid betaine metabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0008270 | Molecular function | zinc ion binding |
GO_0047150 | Molecular function | betaine-homocysteine S-methyltransferase activity |
Gene name | BHMT |
Protein name | Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5) |
Synonyms | hCG_2039815 HEL-S-61p |
Description | FUNCTION: Involved in the regulation of homocysteine metabolism. Converts betaine and homocysteine to dimethylglycine and methionine, respectively. This reaction is also required for the irreversible oxidation of choline. . FUNCTION: Involved in the regulation of homocysteine metabolism. Converts betaine and homocysteine to dimethylglycine and methionine, respectively. This reaction is also required for the irreversible oxidation of choline. . FUNCTION: Involved in the regulation of homocysteine metabolism. Converts betaine and homocysteine to dimethylglycine and methionine, respectively. This reaction is also required for the irreversible oxidation of choline. . |
Accessions | ENST00000524080.1 V9HWA4 Q93088 ENST00000274353.10 E5RJH0 |